COVID-19 Oral Therapeutics Plan
December 27, 2021
Paxlovid and molnupiravir received emergency use authorization the week of December 20th. These oral COVID-19 medications will be critical additions to our toolbelt of treatments against COVID-19 disease. The new therapeutics will play an especially important role as recent data shows that some monoclonal antibody treatments including bamlanivimab/etesevimab and REGEN-COV are unlikely to retain activity against Omicron. While Sotrovimab is expected to retain activity against Omicron, its supply nationwide is limited. NMDOH currently recommends continued use of all monoclonal antibody options as current genomic surveillance information indicates a low prevalence (<1%) of the Omicron variant. The situation is expected to change rapidly, and oral therapeutics will play a large role in treatment as they are expected to retain efficacy against Omicron variant.
While supplies of oral therapeutics are in short supply, distribution and shipping must occur through a phased patient eligibility criteria and a limited pharmacy network will be necessary. Patients outside of the eligibility criteria for oral therapeutics should be managed using other protocols and therapeutics. Supply is anticipated to increase over the next several months.
Current Participating Pharmacy Locations for Oral Therapeutics
The listing of pharmacy locations will expand as supply increases. Please continue to check cv.nmhealth.org COVID-19 Treatment tab, for an up-to-date list of locations.
Prescriptions should be sent to:
Community, A Walgreens Pharmacy
933 San Mateo Blvd NE Suite 501,
Albuquerque, NM 87108
Monday thru Friday from 8:30am to 5:pm
(Weekend Prescriptions Friday 4pm thru Monday 8am need to be sent to a location with store supplies. Please see the table below.)
Prescriptions will be sent via overnight mail across the state directly to the patient’s home or an approved alternate pick up location.
Prescribers should note the date of symptom onset on the prescription. This information is critical for pharmacists to ensure the patient receives their prescription within the treatment window.
*** If you are picking up a prescription, please use drive thru to protect pharmacy staff. ***
Initial locations with In-store supplies of Molnupiravir: